HDL-C Lowering Seen in Some Patients on Fibrate/TZD ComboHDL-C Lowering Seen in Some Patients on Fibrate/TZD Combo

Data from the ACCORD trial suggest that in a small number of patients, perhaps with a particular genetic background, the combination of fenofibrate and a TZD dramatically lowers HDL cholesterol. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news